KRM Ayurveda IPO Debuts with 27% Premium; Shares Hit Upper Circuit

• KRM Ayurveda shares listed on NSE SME at ₹172.10, a 27.48% premium over the IPO price of ₹135.
• The stock further climbed to hit its upper circuit of ₹180.70, closing with a 33.85% gain for IPO investors.
• The ₹77 crore IPO was oversubscribed 74.27 times, with strong interest from QIBs, NIIs, and retail investors.
• Funds from the IPO will be used for telemedicine facilities, CRM software, HR, debt reduction, and working capital.
• KRM Ayurveda operates 6 hospitals and 5 clinics in India, offering Ayurvedic treatments and products, with an international telemedicine presence.

Why It Matters: KRM Ayurveda IPO saw a strong listing, delivering significant gains to investors on its debut.